title: Cyclosporine lowering with everolimus or mycophenolate to preserve renal function in heart recipients: a randomized study.
authors.forename: Luciano
authors.initials: L
authors.lastname: Potena
authors.forename: Isidoro G
authors.initials: IG
authors.lastname: Bianchi
authors.forename: Gaia
authors.initials: G
authors.lastname: Magnani
authors.forename: Marco
authors.initials: M
authors.lastname: Masetti
authors.forename: Fabio
authors.initials: F
authors.lastname: Coccolo
authors.forename: Francesco
authors.initials: F
authors.lastname: Fallani
authors.forename: Antonio
authors.initials: A
authors.lastname: Russo
authors.forename: Francesco
authors.initials: F
authors.lastname: Grigioni
authors.forename: Angelo
authors.initials: A
authors.lastname: Branzi
authors.forename: Claudio
authors.initials: C
authors.lastname: Ponticelli
mesh_terms: D003404:Creatinine / Q000378:metabolism; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D000068338:Everolimus; D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology*; D007677:Kidney Function Tests; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012449:Safety; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000068338:Everolimus; D003404:Creatinine; D009173:Mycophenolic Acid; D020123:Sirolimus